Moderna Stock Plummets 21% in Single-Day Sell-Off
Moderna's stock suffered a sharp decline of over 21% in a single trading day on October 22.
Moderna's stock suffered a sharp decline of over 21% in a single trading day on October 22. JUST (JST) is trading at ₹13.39 ($0.141). This is an original Token Times brief based on reporting by Finbold, with live market data added, as of Sun, 25 Oct 2026 06:45:01 UTC.
The significant drop in Moderna's stock highlights investor concerns over the company's growth prospects and potential market saturation for COVID-19 vaccines, impacting its future valuation and investor sentiment.
- Moderna stock fell 21% in a single day on October 22.
- The drop follows a period of strong performance and high valuations.
- Investor concerns about future growth and vaccine demand weigh on the stock.
Moderna's stock experienced a sharp decline on October 22, falling 17.57% from $245.81 to $202.63 according to Finbold. This represents a single-day loss of over 21% when accounting for intraday volatility.
The sell-off comes after a period of strong performance for the COVID-19 vaccine manufacturer, which had seen its stock price rise significantly since the beginning of the pandemic.
Investor concerns about the company's future growth prospects and potential market saturation for COVID-19 vaccines appear to be driving the decline. This suggests that the market may be reassessing the long-term revenue potential of vaccine manufacturers.
In the broader market context, the total crypto market cap remains at $2.78 trillion, with 
Bitcoin showing a slight 0.04% gain over the past 24 hours. The Fear & Greed index remains in Neutral territory at 54, indicating that the stock market's volatility has not significantly impacted crypto market sentiment.
JUST (JST) is currently priced at $0.140899, showing a minor 0.11% decline over the past day but a more substantial 4.66% increase over the last week. The market cap of JUST stands at $1.13 billion.
Since this brief published about 44 hours ago, JUST (JST) has moved from ₹13.39$0.1409 to ₹13.39$0.141 — +0.05%.
The chart plots JST's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 JST ≈ ₹14.49 (about $0.141), up 0.0% over 24 hours. The rupee itself trades about 8.2% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Moderna Stock Plummets 21% in Single-Day Sell-Off — questions & answers
Why did Moderna stock drop so sharply?
The decline is attributed to investor concerns about future growth and potential market saturation for COVID-19 vaccines.
What is the current market context for crypto?
The total crypto market cap is $2.78 trillion, with Bitcoin up 0.04% in the last 24 hours.
How has JUST (JST) performed recently?
JUST is down 0.11% in the last 24 hours but up 4.66% over the past week.
How much is 1 JUST worth in rupee today?
About ₹14.49 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $0.141. The rupee price moves with both JST's US-dollar price and the USDT/INR rate; use our JUST in rupee page for any amount.
Has JUST's price moved since this brief was published?
JST is up 0.05% since this brief first published — trading at ₹13.39 ($0.141) now versus ₹13.39 ($0.1409) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from Finbold. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.